CPHI Milan · 6–8 October 2026Plan a conversation
CMO · CDMO · R&D

Manufacturing capabilities

Non-sterile dosage forms, formulation development and packaging pathways, matched to the product and its intended market.

Select the platform that fits your product

Oral liquids

Solutions, syrups, suspensions, oral drops and oral sprays. Experience with paediatric liquids and herbal formulations.

Explore

Topical & semisolid

Creams, ointments, gels, emulsions, dermal solutions and pharmaceutical soaps.

Explore

Sprays & drops

Non-sterile nasal solutions and sprays, oral sprays and otic drops, within the relevant site and product-category scope.

Explore

Solid forms

Hard capsules; plain, effervescent, lozenge and coated tablets; powders and effervescent powders in sachets.

Explore

Packaging

Bottles, tubes, sachets, blisters and strips. Container compatibility, line fit and presentation are assessed together.

Explore

Development & analytics

Formulation and reformulation, analytical development, stability programmes, pilot support and technical documentation coordinated with the client’s regulatory team.

Explore

Product categories

Pharmaceuticals for human use, including investigational products; food supplements; cosmetics; and medical devices within the authorised scope. FSMP development requests are assessed separately against the applicable product, manufacturing and regulatory requirements.

The Site 1 authorisation specifically lists nasal sprays for medical devices. A broader device claim is assessed separately; product-specific readiness is confirmed before quotation.